Joseph E. Gilliam - Sep 19, 2024 Form 4 Insider Report for GLAUKOS Corp (GKOS)

Role: PRESIDENT & COO
Signature: Diana Scherer, Attorney-in-Fact
Stock symbol: GKOS
Transactions as of: Sep 19, 2024
Transactions value $: $0
Form type: 4
Date filed: 9/23/2024, 07:15 PM
Previous filing: Aug 23, 2024
Next filing: Nov 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GKOS	Stock Option (Right to Buy)	Award	$0	+14.6K	+40.96%	$0.00	50.4K	Sep 19, 2024	Common Stock	14.6K	$55.18	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating and Governance Committee of the Issuer's Board of Directors determined on September 19, 2024 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets.
F2	25% of the portion of the option reported herein will vest and become exercisable in September 2024. 25% of the portion of the option reported herein will vest and become exercisable in December 2024. 25% of the portion of the option reported herein will vest and become exercisable in May 2025, and the remaining 25% will vest and become exercisable in September 2025.

Content

Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating and Governance Committee of the Issuer's Board of Directors determined on September 19, 2024 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets.

25% of the portion of the option reported herein will vest and become exercisable in September 2024. 25% of the portion of the option reported herein will vest and become exercisable in December 2024. 25% of the portion of the option reported herein will vest and become exercisable in May 2025, and the remaining 25% will vest and become exercisable in September 2025.